1. Kathiresan S., Melander O., Anevski D., Guiducci C., Burtt N. P., Roos C., Hirschhorn J. N., Berglund G., Hedblad B., Groop L., Altshuler D. M., Newton-Cheh C., Orho-Melander M. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events // N Engl J. Med. 358 (12): 1240–1249.
2. Love-Gregory L., Sherva R., Sun L., Wasson J., Schappe T., Doria A., Rao D. C., Hunt S. C., Klein S., Neuman R. J., Permutt M. A., Abumrad N. A. (2008) Variants in CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol // Human Molecular Genetics 17 (11): 1695–1704.
1. National Center for Health Statistics, “Deaths – leading causes,” cdc.gov/nchs/FASTATS/lcod.htm
.1. Holmes T., Rahe R. (1967) The social readjustment rating scale // Psychosom Res 11 (2): 213–218.
2. Weber G. (2004) Weber G. (2004) Lost time: Vacation days go unused despite more liberal time-off policies. Workforce Man. Dec: 66–67 workforce.com/section/02/feature/23/89/82/index.html
.3. Haskell C. F., Kennedy D. O., Milne A. L., Wesnes K. A., Scholey A. B. (2008) The effects of 1-the-anine, caffeine and their combination on cognition and mood // Bio Psych 77 (2): 113–122.
4. Zaret B. L., Moser M., Cohen L. S. (1992) Yale University School of Medicine Heart Book med.yale.edu/library/heartbk/p.97
.5. Moyer C. A., Rounds J., Hannum J. W. (2004) A meta-analysis of massage therapy research // Psych Bull 130 (1): 3–18.
6. Benson H., Beary J. F., Carol M. P. (1974) The relaxation response // Psychiatry 37 (l): 37–46.
7. Klag M. J, Wang N. Y., Meoni L. A., Brancati F. L., Cooper L. A., Liang K. Y., Young J. H., Ford D. E. (2002) Coffee intake and risk of hypertension: The Johns Hopkins precursors study // Arch Intern Med 162 (6): 657–662.
8. El Yacoubi M., Ledent C., Parmentier M., Costentin J., Vaugeois J.M. (2000) The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists // Psychopharmacology (Berl) 148 (2): 153–163.
9. Haskell C. F., Kennedy D. O., Milne A. L., Wesnes K. A., Scholey A. B. (2007) The effects of L-theanine, caffeine and their combination on cognition and mood // Biol Psychol 77 (2): 113–122.
1. van Dam R. M., Li T., Spiegelman D., Franco O. H., Hu F. B. (2008) Combined impact of lifestyle factors on mortality: Prospective cohort study in US women // BMJ 337: al 440.
2. Kosters J. P., Gotzsche P. C. (2003) Regular self-examination or clinical examination for early detection of breast cancer // Cochrane Database of Systematic Reviews 2: CD003373. DOI: 10.1002/14651858.CD003373
.1. O’Keefe J. H., Gheewala N. M., O’Keefe J. O. Стратегия правильного питания в целях улучшения показателей постпрандиальных уровней глюкозы и липидов, устранения воспаления и улучшения состояния сердечно-сосудистой системы // JACC, Т. 2 № 4, 2009, С. 164–170.
2. MedWireNews, September 28, 2007, “Alcohol amount, not type, affects breast cancer risk”.
3. Sesso H. D., Paffenbarger Jr. R. S., Lee I. M. (2001) Alcohol consumption and risk of prostate cancer: The Harvard Alumni Health Study // Int J of Epi 30: 749–755.
4. Johnston C. S., Kim C. M., Buller A. J. (2004) Vinegar improves insulin sensitivity to a high-carbohydrate meal in subjects with insulin resistance or type 2 diabetes // Diabetes Care 27: 281–282.
1. Ames B. N., Wakimoto P. (2002) Are vitamin and mineral deficiencies a major cancer risk? // Nature Reviews Cancer 2: 694–704.
2. University Medical Center Rotterdam, “The Rotterdam Study,” epib.nl/ergo.htm
.3. Losonczy K. G., Harris T. B., Havlik R. J. (1996) Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies in the Elderly // Am J. Clin Nutr 64 (2): 190–196.
4. Li H., Stampfer M. J., Giovannucci E. L., Morris J. S., Willett W. C., Gaziano J.M., Ma J. (2004) A prospective study of plasma selenium levels and prostate cancer risk // J. Natl Cancer Inst 96 (9): 696–703.
5. Miller E. R., Pastor-Barriuso R., Dalai D., Riemersma R. A., Appel L. J., Guallar E. (2005) Metaanalysis: High-dosage vitamin E supplementation may increase all-cause mortality // Ann Intern Med 142: 37–46.
6. Ames B. N., Elson-Schwab I., Silver E. A. (2002) High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): Relevance to genetic disease and polymorphisms // Amer J. of Clin Nut 75 (4): 616–658.